WO2026138849 - CANINE RECOMBINANT ALLERGEN VACCINE, PREPARATION METHOD THEREFOR, AND USE THEREOF
National phase entry is expected:
Publication Number
WO/2026/138849
Publication Date
02.07.2026
International Application No.
PCT/CN2025/144997
International Filing Date
24.12.2025
Title **
[English]
CANINE RECOMBINANT ALLERGEN VACCINE, PREPARATION METHOD THEREFOR, AND USE THEREOF
[French]
VACCIN RECOMBINANT CONTRE LES ALLERGÈNES CANINS, SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION
[Chinese]
狗重组变应原疫苗及其制备方法和应用
Applicants **
ZONHON BIOPHARMA INSTITUTE, INC.
Inventors
MA, Bruce Yong
ZHAO, Baixue
WU, Cheng
GAO, Hui
ZHUANG, Yu
Priority Data
202411915495.0
24.12.2024
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1899 | |
| EPO | Filing, Examination, Granting | 12621 | |
| Japan | Filing, Examination, Granting | 2250 | |
| South Korea | Filing, Examination, Granting | 2266 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
23,776
Contact Us
Abstract[English]
Provided are a canine recombinant allergen vaccine, a pharmaceutical composition thereof, a preparation method therefor, and a use thereof. The canine recombinant allergen vaccine is used for identifying, during diagnosis, an allergen molecule causing an allergic reaction, and is used for performing allergen immunotherapy on a patient during treatment.[French]
L'invention concerne un vaccin recombinant contre les allergènes canins, une composition pharmaceutique de celui-ci, son procédé de préparation et son utilisation. Le vaccin recombinant contre les allergènes canins est utilisé pour identifier, pendant le diagnostic, une molécule d'allergène provoquant une réaction allergique, et est utilisé pour effectuer une immunothérapie allergène sur un patient pendant le traitement.[Chinese]
提供了狗重组变应原疫苗及其药用组合物、制备方法和应用。用于诊断时鉴别过敏反应的变应原分子，用于治疗时对患者实施过敏原免疫疗法。